Kovač, MD, PhD, V.; Zwitter, M.; Stanic, K.; Rajer, M.; Kern, I.; Vrankar, M.; Edelbaher, N. Intercalated Chemotherapy and Erlotinib for Advanced NSCLC: High Proportion of Complete Remissions and Prolonged Progression-Free Survival Among Patients With EGFR Activating Mutations. Radiol Oncol 2014, 48.